Company Filing History:
Years Active: 2016
Title: Angele Moryusef: Innovator in Cardiac Treatment
Introduction
Angele Moryusef is a prominent inventor based in Bridgewater, NJ (US). She has made significant contributions to the field of medicine, particularly in the treatment of non-ST elevation myocardial infarction in elderly and renal-impaired patients. Her innovative approach has the potential to improve patient outcomes and enhance the quality of care for vulnerable populations.
Latest Patents
Angele Moryusef holds a patent for her invention titled "Otamixaban for treatment of elderly and renal impaired non-ST elevation myocardial infarction patients." This patent involves the use of (2R,3R)-2-(3-carbamimidoyl-benzyl)-3-[4-(1-oxy-pyridin-4-yl)benzoylamino]-butyric acid methyl ester or a pharmaceutically acceptable salt thereof. The invention focuses on preparing a medicament for use in non-ST elevation myocardial infarction, specifically targeting elderly patients and those with renal insufficiency or low body weight.
Career Highlights
Angele Moryusef is associated with Sanofi, a leading global healthcare company. Her work at Sanofi has allowed her to collaborate with other talented professionals in the field. She has made strides in developing treatments that address critical health issues, showcasing her dedication to advancing medical science.
Collaborations
Angele has worked alongside notable colleagues such as Jens Stechl and Christophe Gaudin. Their combined expertise has contributed to the success of her innovative projects and the development of effective treatments.
Conclusion
Angele Moryusef's contributions to cardiac treatment exemplify the impact of innovation in healthcare. Her patent for Otamixaban highlights her commitment to improving the lives of patients with specific medical needs. Through her work at Sanofi and collaborations with esteemed colleagues, she continues to pave the way for advancements in medical treatments.